Adverse Effects: Hypertension Peripheral ischemia or necrosis (with prolonged use) Reflex bradycardia Arrhythmias (rare) Key Monitoring Parameters: Continuous blood pressure (invasive or non-invasive) Urine output (for perfusion adequacy) Cardiac rhythm and lactate levels Pharmacists Note: Avoid abrupt discontinuation gradually taper the dose
Reporting Suspected Side Effects How to report suspected side effects or adverse reactions to medicines MHRA Yellow Card Scheme Medically Reviewed by Our GPhC-Registered Pharmacists Authored by: Palvinder Deol Superintendent Pharmacist Over 25 years clinical experience
doi:10.1016/j.phymed.2012.12.018 Chen CY, Leu YL, Fang Y, et al
Endpoint definitions To evaluate L-carnitine effectiveness, we determined the three following endpoints in each patient: (1) VPA elimination half-life ( t 1/2 )
Low-Density Lipoproteins : Low-density lipoproteins are commonly known as the LDL lipoproteins
We want to ensure that now and then we introduce some variety into our programme, this really ensures we are maximising our muscle-building potential
